![](/img/cover-not-exists.png)
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
Patrikidou, A., Chabaud, S., Ray-Coquard, I., Bui, B. N., Adenis, A., Rios, M., Bertucci, F., Duffaud, F., Chevreau, C., Cupissol, D., Domont, J., Perol, D., Blay, J. Y., Le Cesne, A.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mds587
Date:
April, 2013
File:
PDF, 164 KB
english, 2013